EFFICIENT INCORPORATION OF ANTI-HIV DEOXYNUCLEOTIDES BY RECOMBINANT YEAST MITOCHONDRIAL-DNA POLYMERASE

被引:47
作者
ERIKSSON, S [1 ]
XU, BJ [1 ]
CLAYTON, DA [1 ]
机构
[1] STANFORD UNIV,SCH MED,BECKMAN CTR MOLEC & GENET MED,DEPT DEV BIOL,STANFORD,CA 94305
关键词
D O I
10.1074/jbc.270.32.18929
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Saccharomyces cerevisiae mtDNA polymerase, isolated as a single 135-kDa recombinant polypeptide, showed high processivity and a capacity to use poly(dA). oligo(dT), poly(rA). oligo(dT), or primed bacteriophage M13 DNA as a template, In a primer extension assay, the enzyme exhibited an intrinsic 3'-5'-exonuclease activity, By optimizing the polymerization reaction conditions, apparent K-m and V-max values could be determined for the incorporation of dTTP, 2'-3'-dideoxy-TTP (ddTTP), 3'-azido-TTP (AZTTP), 3'-fluoro-TTP, dCTP, 2'-3'-dideoxy-CTP, and didehydro(d4)CTP, The yeast mtDNA polymerase used ddTTP, 3'-fluoro-TTP, and ddCTP almost as efficiently as natural deoxynucleoside triphosphates. Both 3'-AZTTP and d4CTP were each significantly less efficient as substrates. Overall, the kinetic data with mtDNA polymerase were very similar to those of the recombinant human immunodeficiency virus reverse transcriptase control, Terminally incorporated AZTTP or ddTTP was not removed by the 3'-5' exonuclease activity of mtDNA polymerase. This may explain the inhibition of mtDNA replication observed in anti-human immunodeficiency virus treatment with dideoxynucleoside analogs and suggests that screening of antiviral nucleosides for their effects on mtDNA polymerase could be of value in future rational drug design.
引用
收藏
页码:18929 / 18934
页数:6
相关论文
共 44 条
  • [1] DEPLETION OF MUSCLE MITOCHONDRIAL-DNA IN AIDS PATIENTS WITH ZIDOVUDINE-INDUCED MYOPATHY
    ARNAUDO, E
    DALAKAS, M
    SHANSKE, S
    MORAES, CT
    DIMAURO, S
    SCHON, EA
    [J]. LANCET, 1991, 337 (8740) : 508 - 510
  • [2] BOTH 2',3'-DIDEOXYTHYMIDINE AND ITS 2',3'-UNSATURATED DERIVATIVE (2',3'-DI-DEOXYTHYMIDINENE) ARE POTENT AND SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-REPLICATION INVITRO
    BABA, M
    PAUWELS, R
    HERDEWIJN, P
    DECLERCQ, E
    DESMYTER, J
    VANDEPUTTE, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 142 (01) : 128 - 134
  • [3] BOGENHAGEN D, 1976, J BIOL CHEM, V251, P2938
  • [4] BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689
  • [5] CHEN CH, 1989, J BIOL CHEM, V264, P11934
  • [6] CHEN CH, 1991, MOL PHARMACOL, V39, P625
  • [7] CHENG YC, 1987, J BIOL CHEM, V262, P2187
  • [8] COPELAND WC, 1992, J BIOL CHEM, V267, P21459
  • [9] MITOCHONDRIAL MYOPATHY CAUSED BY LONG-TERM ZIDOVUDINE THERAPY
    DALAKAS, MC
    ILLA, I
    PEZESHKPOUR, GH
    LAUKAITIS, JP
    COHEN, B
    GRIFFIN, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (16) : 1098 - 1105
  • [10] 5-CHLORO-2',3'-DIDEOXY-3'-FLUOROURIDINE (935U83), A SELECTIVE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS AGENT WITH AN IMPROVED METABOLIC AND TOXICOLOGICAL PROFILE
    DALUGE, SM
    PURIFOY, DJM
    SAVINA, PM
    STCLAIR, MH
    PARRY, NR
    DEV, IK
    NOVAK, P
    AYERS, KM
    REARDON, JE
    ROBERTS, GB
    FYFE, JA
    BLUM, MR
    AVERETT, DR
    DORNSIFE, RE
    DOMIN, BA
    FERONE, R
    LEWIS, DA
    KRENITSKY, TA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) : 1590 - 1603